title: The effect of NOD2 on the microbiota in Crohn's disease.
abstract: Recent advancements toward the treatment of Crohn's disease (CD) indicate great promise for long-term remission. CD patients suffer from a complex host of dysregulated interactions between their innate immune system and microbiome. The most predominant link to the onset of CD is a genetic mutation in the innate immune receptor nucleotide-binding oligomerization domain-containing 2 (NOD2). NOD2 responds to the presence of bacteria and stimulates the immune response. Mutations to NOD2 promote low diversity and dysbiosis in the microbiome, leading to impaired mucosal barrier function. Current treatments suppress the immune response rather than enhancing the function of this critical protein. New progress toward stabilizing NOD2 signaling through its interactions with chaperone proteins holds potential in the development of novel CD therapeutics.
authors.affiliation: University of Delaware, Department of Chemistry & Biochemistry, Newark, DE 19716, United States.
authors.forename: Mackenzie L
authors.initials: ML
authors.lastname: Lauro
authors.affiliation: University of Delaware, Department of Chemistry & Biochemistry, Newark, DE 19716, United States.
authors.forename: Jason M
authors.initials: JM
authors.lastname: Burch
authors.affiliation: University of Delaware, Department of Chemistry & Biochemistry, Newark, DE 19716, United States. Electronic address: cgrimes@udel.edu.
authors.forename: Catherine Leimkuhler
authors.initials: CL
authors.lastname: Grimes
mesh_terms: D000818:Animals; D003424:Crohn Disease / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D064307:Microbiota / Q000235:genetics / Q000276:immunology*; D009154:Mutation / Q000235:genetics*; D053473:Nod2 Signaling Adaptor Protein / Q000235:genetics* / Q000378:metabolism
chemical_list: D053473:Nod2 Signaling Adaptor Protein